No Prescription |
 |
 | ||
|
Distaclor CD Ceclor |
|
| ||
No Prescription » Prescription Drugs 6 » Distaclor CD Ceclor Cefaclor is used to treat certain infections caused by bacteria such as pneumonia and infections of the ears lungs throat urinary tract and skin. Cefaclor is in a class of medications called cephalosporin antibiotics. It works by stopping the growth of bacteria. Antibiotics will not work for colds flu or other viral infections.Cefaclor comes as a capsule an extended-release (long-acting) tablet and a suspension (liquid) to take by mouth. The capsule and liquid are usually taken every 8 hours (three times a day) or every 12 hours (twice a day). The long-acting tablet is usually taken every 12 hours (twice a day) within 1 hour of eating a meal. To help you remember to take cefaclor take it around the same time every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take cefaclor exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Buy Distaclor CD Ceclor and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About Distaclor CD Ceclor: Product Type: Prescription Drugs 6 Distaclor CD (Ceclor Generic Cefaclor) Distaclor CD (Ceclor Generic Cefaclor) Ceclor Generic Cefaclor 375mg 30 Tablets 3 x 30 Tablets Ceclor Generic Cefaclor Distaclor CD
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
